Not Yet Recruiting Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML NCT07157514 Conditions Acute Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, +15 more Locations Not specified View Trial Details
Completed Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies. NCT04965649 Conditions BCR-ABL Positive Acute Myeloid Leukemia, Chronic Leukemia, Hematologic Diseases, +6 more Locations CHU de Nîmes — Nîmes, Gard, France View Trial Details
Completed Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus NCT00133367 Conditions Blood Protein Disorders, Cardiovascular Diseases, Graft vs Host Disease, +27 more Locations Massachusetts General Hospital — Boston, Massachusetts, United States Dana-Farber Cancer Institute — Boston, Massachusetts, United States View Trial Details
Completed Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation NCT00144703 Conditions Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Graft vs Host Disease, +23 more Locations Dana-Farber Cancer Institute — Boston, Massachusetts, United States View Trial Details
